Ohio State University Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.osu.edu

Clinical Trials

B3 Buddy for Securing Urinary Drainage Bag to Patient While Walking

Not Applicable

Recruiting

Conditions: Urinary System Disorder

Interventions: Other: Assistance
Other: Educational Intervention
Other: Medical Device Usage and Evaluation
Other: Questionnaire Administration
Other: Walking
Procedure: Remove

First Posted Date: 2024-08-26

Last Posted Date: 2024-08-26

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT06571058

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Not Applicable

Active, not recruiting

Conditions: BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

Interventions: Procedure: Biospecimen Collection
Other: Best Practice
Other: Counseling
Procedure: Discussion
Other: Questionnaire Administration
Procedure: Genotyping
Procedure: Molecular Risk Assessment

First Posted Date: 2024-08-02

Last Posted Date: 2024-08-02

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 152

Registration Number: NCT06534424

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

Not Applicable

Recruiting

Conditions: Soft Tissue Sarcoma

Interventions: Procedure: Computed Tomography
Radiation: Gallium Ga 68-HA-DOTA-TATE
Procedure: Positron Emission Tomography

First Posted Date: 2024-07-15

Last Posted Date: 2024-10-31

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT06500065

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Manipulating E-Cigarette Nicotine to Promote Public Health

Not Applicable

Recruiting

Conditions: Tobacco-Related Carcinoma

Interventions: Procedure: Biospecimen Collection
Procedure: Carbon Monoxide Measurement
Other: Vaping session
Other: Survey Administration

First Posted Date: 2024-06-07

Last Posted Date: 2024-06-07

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 350

Registration Number: NCT06448351

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial

Not Applicable

Recruiting

Conditions: Lung Carcinoma

Interventions: Procedure: Biospecimen Collection
Other: Best Practice
Other: Exercise Counseling
Other: Medical Device Usage and Evaluation
Other: Exercise Intervention
Other: Physical Performance Testing
Other: Questionnaire Administration
Other: Telemedicine

First Posted Date: 2024-06-06

Last Posted Date: 2024-06-06

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT06445192

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

Early Phase 1

Not yet recruiting

Conditions: Low Anterior Resection Syndrome
Rectal Carcinoma

Interventions: Dietary Supplement: Dietary Fiber
Procedure: Enema Administration
Drug: Loperamide Hydrochloride
Procedure: Physical Therapy
Other: Questionnaire Administration
Procedure: X-Ray Imaging

First Posted Date: 2024-05-22

Last Posted Date: 2024-06-03

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 80

Registration Number: NCT06424522

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer

Not Applicable

Recruiting

Conditions: Malignant Thoracic Neoplasm

Interventions: Other: Educational Activity
Other: Electronic Health Record Review
Other: Internet-Based Intervention
Other: Media Intervention
Other: Survey Administration

First Posted Date: 2024-05-02

Last Posted Date: 2024-05-02

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 157

Registration Number: NCT06396598

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Not Applicable

Not yet recruiting

Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8
Metastatic Cutaneous Melanoma
Metastatic Renal Cell Carcinoma
Stage IV Renal Cell Cancer AJCC v8

Interventions: Procedure: Biospecimen Collection
Other: Best Practice
Procedure: Computed Tomography
Other: Dietary Intervention
Other: Educational Activity
Other: Glucose Measurement
Other: Ketone Measurement
Other: Questionnaire Administration

First Posted Date: 2024-04-30

Last Posted Date: 2024-04-30

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT06391099

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

Phase 2

Not yet recruiting

Conditions: Prostate Adenocarcinoma
Stage IIB Prostate Cancer AJCC v8
Stage IIC Prostate Cancer AJCC v8

Interventions: Procedure: Biospecimen Collection
Other: Contrast Agent
Drug: Leuprolide
Procedure: Magnetic Resonance Imaging
Other: Physical Performance Testing
Drug: Relugolix

First Posted Date: 2024-03-26

Last Posted Date: 2024-03-26

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 70

Registration Number: NCT06330805

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Phase 2

Recruiting

Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Oropharyngeal Squamous Cell Carcinoma
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Interventions: Procedure: Biospecimen Collection
Drug: Carboplatin
Drug: Cisplatin
Procedure: Computed Tomography
Radiation: External Beam Radiation Therapy
Drug: Paclitaxel
Procedure: Positron Emission Tomography
Other: Questionnaire Administration

First Posted Date: 2024-03-21

Last Posted Date: 2024-03-21

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 45

Registration Number: NCT06323460

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy